Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) has shared an announcement.
Shanghai Haohai Biological Technology Co., Ltd. has announced an interim cash dividend of RMB 0.4 per share for the six-month period ending June 30, 2025. The dividend will be paid in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.096155, with a payment date set for October 17, 2025. The announcement reflects the company’s financial health and commitment to returning value to its shareholders. The dividend distribution also involves withholding tax implications for both resident and non-resident shareholders, with varying rates based on residency and applicable tax treaties.
The most recent analyst rating on (HK:6826) stock is a Buy with a HK$33.00 price target. To see the full list of analyst forecasts on Shanghai Haohai Biological Technology Co., Ltd. Class H stock, see the HK:6826 Stock Forecast page.
More about Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. operates in the biotechnology industry, focusing on the development and production of biological materials and medical devices. The company is known for its innovative solutions in ophthalmology, medical aesthetics, and wound care, serving both domestic and international markets.
Average Trading Volume: 724,660
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$13.11B
For detailed information about 6826 stock, go to TipRanks’ Stock Analysis page.